Medicine in Drug Discovery
Publisher: Elsevier · ISSN 2590-0986 · 11 articles
- Therapeutic capabilities of naturally-derived p38 MAPK inhibitors for protecting the cerebrovascular system in severe SARS‑CoV‑2 infection
- Cyanobacterial peptides and polyketides: biosynthetic basis, structural diversity and therapeutic relevance
- Harnessing QSAR and machine learning for the design of hepatocellular carcinoma inhibitors; experimental validation of the cytotoxicity of new compounds against HepG2 cells
- Rhinacanthins from Rhinacanthus nasutus inhibit the Plasmodium falciparum mitochondrial cytochrome bc1 complex revealed by chemical genetic and in silico studies
- Natural products triggering non-apoptotic regulated cell death in lung cancer: A systematic review focusing on pyroptosis, with insights into cuproptosis and necroptosis
- Duration of tenofovir disoproxil fumarate treatment and a rapid eGFR decline in a retrospective cohort of people living with HIV infection
- Phenanthrene and dihydrophenanthrene derivatives from Vanda curvifolia with cytotoxic activity against glioblastoma cells
- Efficacy and safety of difluprednate for macular edema management: a systematic review and meta-analysis
- 5-O-(3-Indolecarbonyl) Renieramycin T suppresses c-Myc and cancer stemness in colorectal cancer cells: insights from computational and experimental studies
- From mushroom metabolome to prioritized anti-diabetic metabolite candidates: LC-MS/MS and AIDDISON™-assisted screening of Pleurotus citrinopileatus
- GPCR-PTM: an interpretable, topology-aware rule-based framework for residue-level post-translational modification annotation and prediction across the human GPCRome